Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most compelling evidence for the causal role of telomere shortening as a primary modifier of disease is that families with mutant telomerase genes display genetic anticipation39,83.”
From The telomere syndromes (2012) · cites this paper as [83]
In the citing paper
“Telomere length is influenced by many different factors, including age (13, 14) and the number of generations the mutation is transmitted (6, 15).”
From Adult-onset pulmonary fibrosis caused by mutations in telomerase (2007) · cites this paper as [15]
Citations
Cites
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.002005 · Cited by 1,021
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976
Self-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Self-citationDyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Self-citationExtensive allelic variation and ultrashort telomeres in senescent human cells
Baird, D. M., Rowson, J., Wynford-Thomas, D., & Kipling, D. (2003) · Nature Genetics · doi:10.1038/ng1084 · Cited by 570
Function and synthesis of small nucleolar RNAs
Tollervey, D., & Kiss, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80005-1 · Cited by 467
Structure and polymorphism of human telomere-associated DNA
Brown, W. R. A., MacKinnon, P. J., Villasanté, A., Spurr, N., Buckle, V. J., & Dobson, M. J. (1990) · Cell · doi:10.1016/0092-8674(90)90293-n · Cited by 375
Association between aplastic anaemia and mutations in telomerase RNA
Vulliamy, T., Marrone, A., Dokal, I., & Mason, P. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09087-6 · Cited by 279
Self-citation
Cited by
Telomeres and human disease: ageing, cancer and beyond
Blasco, M. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1656 · Cited by 1,434
“These mutations affect either the Terc gene (patients with the autosomal dominant DC variant”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Aubert, G., & Lansdorp, P. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00026.2007 · Cited by 1,188
“The latter results in disease anticipation in family trees of patients with telomerase-related genetic defects (218).”
BackgroundArmanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging
Blackburn, E. H., Greider, C. W., & Szostak, J. W. (2006) · Nature Medicine · doi:10.1038/nm1006-1133 · Cited by 880
“Remarkably, mutations in both the RNA and the protein components of telomerase result in progressive telomere shortening over many generations in humans, which limits tissue renewal capacit”
BackgroundShort telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805
Calado, R. T., & Young, N. S. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0903373 · Cited by 754
Telomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747
“These mutations affect either the TERC and TERT genes (people with the autosomal dominant dyskeratosis congenita variant”
BackgroundTelomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723
“Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anemia in Caucasian population.”
BackgroundThe genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Sperling, A. S., Gibson, C. J., & Ebert, B. L. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.112 · Cited by 678
“Telomerase complex disorders: due to mutations in genes encoding members of the telomerase complex (dyskerin pseudouridine synthase 1 (DKC1), telomerase reverse transcriptase (TERT), telomerase RNA component (TERC), GAR1 ribonucleoprotein (GAR1) 169–172 .”
Pathophysiology and management of inherited bone marrow failure syndromes
Shimamura, A., & Alter, B. P. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.03.002 · Cited by 552
Armanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426
“Telomere shortening in response to mutation of the gene encoding telomerase is associated with impaired organ maintenance and shortened lifespan in human”
BackgroundZhu, X., Chen, Z., Shen, W., Huang, G., Sedivy, J. M., Wang, H., & Ju, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00646-9 · Cited by 393
Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010680 · Cited by 377
“Autosomal dominant DKC due to mutations in TERC, which encodes hTR, or TERT can demonstrate disease anticipation with increasing severity and an earlier onset in successive generations [10,30].”
BackgroundAlter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood · doi:10.1182/blood-2007-02-075598 · Cited by 356
Cellular senescence and organismal aging
Jeyapalan, J. C., & Sedivy, J. M. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.001 · Cited by 346
Telomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347
“This observation is supported by the fact that in families that carry mutant telomerase genes and display autosomal dominant inheritance, the disease worsens and appears earlier with each successive generation as the telomere length shortens (12, 64).”
Vulliamy, T. J., Marrone, A., Knight, S. W., Walne, A., Mason, P. J., & Dokal, I. (2006) · Blood · doi:10.1182/blood-2005-07-2622 · Cited by 345
“Sporadic affected female 0 (0) 0 (0) 35 (7) 35 (7)”
Self-citationTelomeres: Cancer to Human Aging
Stewart, S. A., & Weinberg, R. A. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104518 · Cited by 334
“Interestingly, this disease also appears to demonstrate anticipation (symptoms increasing in severity with each succeeding organismic generation), although more patient families must be analyzed to confirm this (Vulliamy et al. 2004).”
BackgroundChemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA
Xu, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00134a · Cited by 323
Walne, A. J., Vulliamy, T., Beswick, R., Kirwan, M., & Dokal, I. (2008) · Blood · doi:10.1182/blood-2008-05-153445 · Cited by 317
Self-citationSyndromes of Telomere Shortening
Armanios, M. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150046 · Cited by 317
“I have summarized these features based on the literature and observations from our cohort and clinical experience (Table 2) (2, 5,6,15,38,73).”
BackgroundMethodWalne, A. J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.-H., Aljurf, M., & Dokal, I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm111 · Cited by 316
“to previously reported and now updated data from other patients with DC (13,17,19,22).”
ResultSelf-citationTelomere length homeostasis requires that telomerase levels are limiting
Cristofari, G., & Lingner, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600952 · Cited by 314
Stuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., Torres, F., Kaza, V., Girod, C. E., Jones, K. D., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70124-9 · Cited by 310
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
Hao, L.-Y., Armanios, M., Strong, M. A., Karim, B., Feldser, D. M., Huso, D., & Greider, C. W. (2005) · Cell · doi:10.1016/j.cell.2005.11.020 · Cited by 302
“Families with autosomal-dominant dyskeratosis congenita have mutations in telomerase components (Vulliamy et al., 2001; Armanios et al., 2005) and display anticipation, an earlier onset, and increasing severity of phenotypes with each generation (Dokal, 2000; Vulliamy et al., 2004).”
BackgroundInfluentialBone marrow failure and the telomeropathies
Townsley, D. M., Dumitriu, B., & Young, N. S. (2014) · Blood · doi:10.1182/blood-2014-05-526285 · Cited by 291
Ju, Z., Jiang, H., Jaworski, M., Rathinam, C., Gompf, A., Klein, C., Trumpp, A., & Rudolph, K. L. (2007) · Nature Medicine · doi:10.1038/nm1578 · Cited by 284
“Telomerase gene mutations limit telomere maintenance and organ homeostasis, and reduce lifespan in mice and human”
BackgroundDokal, I. (2011) · Hematology · doi:10.1182/asheducation-2011.1.480 · Cited by 266
Self-citationDisruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita
Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E. (2011) · Genes & Development · doi:10.1101/gad.2006411 · Cited by 262
“2005) and TERC (Vulliamy et al. 2004), which comprise the catalytic core of the enzyme; dyskerin (DKC1) (Mitchell et al.”
BackgroundSavage, S. A., & Alter, B. P. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.003 · Cited by 262
“Mutations in the TERC gene are present in patients who have DC and occur in an AD manner or de novo.(26) TERC muta-”
BackgroundBatista, L. F. Z., Pech, M. F., Zhong, F. L., Nguyen, H. N., Xie, K. T., Zaug, A. J., Crary, S. M., Choi, J., Sebastiano, V., Cherry, A., et al. (2011) · Nature · doi:10.1038/nature10084 · Cited by 260
“Thus, our findings in TERT-mutant iPSCs are compatible with a mechanism of telomerase haploinsufficiency, whereby a 50% reduction in activity is the cause of disease in this form of DC 21,22 .”
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
Armanios, M., Alder, J. K., Parry, E. M., Karim, B., Strong, M. A., & Greider, C. W. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.10.028 · Cited by 257
“In families, the organ failure displays anticipation, an earlier and more severe onset with each generation, which is associated with progressive telomere shortening.(5,7) These observations have implicated telomere length as an important modifier of disease penetrance in families that carry mutant telomerase genes.”
BackgroundThe genetics and clinical manifestations of telomere biology disorders
Savage, S. A., & Bertuch, A. A. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f415b5 · Cited by 258
Telomerase and idiopathic pulmonary fibrosis
Armanios, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.013 · Cited by 245
“In autosomal dominant DC, there is progressive shortening of telomeres across generations which causes genetic anticipation, similar to what is seen in the telomerase knockout mouse[30, 35].”
BackgroundGenetics of human telomere biology disorders
Revy, P., Kannengiesser, C., & Bertuch, A. A. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00527-z · Cited by 234
Dyskeratosis congenita: a genetic disorder of many faces
Kirwan, M., & Dokal, I. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00923.x · Cited by 236
Self-citationGermline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita
Ballew, B. J., Yeager, M., Jacobs, K., Giri, N., Boland, J., Burdett, L., Alter, B. P., & Savage, S. A. (2013) · Human Genetics · doi:10.1007/s00439-013-1265-8 · Cited by 238
“pattern of genetic anticipation, including the presence of clinically silent mutation carriers, has been seen previously in DC (Armanios et al. 2005; Savage and Bertuch 2010; Vulliamy et al. 2004), and has been used to inform DCrelated gene discovery (Savage et al.”
Telomere maintenance and human bone marrow failure
Calado, R. T., & Young, N. S. (2008) · Blood · doi:10.1182/blood-2007-08-019729 · Cited by 220
Telomere Dynamics in Mice and Humans
Calado, R. T., & Dumitriu, B. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.03.030 · Cited by 214
Ballew, B. J., & Savage, S. A. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.23 · Cited by 209
Vulliamy, T. J., Walne, A., Baskaradas, A., Mason, P. J., Marrone, A., & Dokal, I. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2004.12.008 · Cited by 211
Self-citationTelomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita
Wong, J. M. Y., & Collins, K. (2006) · Genes & Development · doi:10.1101/gad.1476206 · Cited by 202
“X-linked DC is more severe than AD DC in its earlier onset and broader spectrum of affected tissues, with the notable exception of the increasing severity of AD DC disease with anticipation (Vulliamy et al. 2004).”
BackgroundTERT promoter mutations in telomere biology
Heidenreich, B., & Kumar, R. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.11.002 · Cited by 197
Telomere shortening in human diseases
Kong, C. M., Lee, X. W., & Wang, X. (2013) · The FEBS Journal · doi:10.1111/febs.12326 · Cited by 194
Parry, E. M., Alder, J. K., Qi, X., Chen, J. J.-L., & Armanios, M. (2011) · Blood · doi:10.1182/blood-2010-11-322149 · Cited by 194
Genetic predisposition to hematologic malignancies: management and surveillance
Godley, L. A., & Shimamura, A. (2017) · Blood · doi:10.1182/blood-2017-02-735290 · Cited by 190
Constitutional telomerase mutations are genetic risk factors for cirrhosis
Calado, R. T., Brudno, J., Mehta, P., Kovacs, J. J., Wu, C., Zago, M. A., Chanock, S. J., Boyer, T. D., & Young, N. S. (2011) · Hepatology · doi:10.1002/hep.24173 · Cited by 188
“In patients with telomerase deficiency due to telomerase mutations, enzyme function is reduced by haploinsufficiency and telomere shortening may be less intense and clinical phenotype may be less pronounced.(51) In patients with TERT or TERC mutations, aplastic anemia or pulmonary fibrosis may be the only clinical pre…”
BackgroundStructure and function of telomerase RNA
Theimer, C. A., & Feigon, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.05.005 · Cited by 187
Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
Calado, R. T., Regal, J. A., Hills, M., Yewdell, W. T., Dalmazzo, L. F., Zago, M. A., Lansdorp, P. M., Hogge, D., Chanock, S. J., Estey, E. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807057106 · Cited by 184
“Disease anticipation, in which clinical manifestations are more severe or appear at younger ages with succeeding generations, is observed in DKC as a result of inheritance of a deficient telomerase gene with a set of chromosomes with short telomeres (21).”
BackgroundInfluentialInTERTpreting telomerase structure and function
Wyatt, H. D. M., West, S. C., & Beattie, T. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq370 · Cited by 184
Cancer and ageing: convergent and divergent mechanisms
Serrano, M., & Blasco, M. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2242 · Cited by 182
Exome Sequencing Identifies Mutant TINF2 in a Family With Pulmonary Fibrosis
Alder, J. K., Stanley, S. E., Wagner, C. L., Hamilton, M., Hanumanthu, V. S., & Armanios, M. (2015) · Chest · doi:10.1378/chest.14-1947 · Cited by 181
Dyskeratosis congenita, stem cells and telomeres
Kirwan, M., & Dokal, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.010 · Cited by 180
“Inherited forms of the disease also demonstrate the phenomenon of anticipation [11-13] whereby successive generations of an affected”
BackgroundSelf-citationNiewisch, M. R., & Savage, S. A. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1662720 · Cited by 174
Risques, R. A., Lai, L. A., Brentnall, T. A., Li, L., Feng, Z., Gallaher, J., Mandelson, M. T., Potter, J. D., Bronner, M. P., & Rabinovitch, P. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.008 · Cited by 179
Marrone, A., Walne, A., Tamary, H., Masunari, Y., Kirwan, M., Beswick, R., Vulliamy, T., & Dokal, I. (2007) · Blood · doi:10.1182/blood-2006-12-062851 · Cited by 178
Self-citationAdvances in the understanding of dyskeratosis congenita
Walne, A. J., & Dokal, I. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07598.x · Cited by 175
“However in the child with the same heterozygous TERC mutation the disease manifests itself at a much younger age (Vulliamy et al, 2004).”
BackgroundSelf-citationDNA Repair Defects in Stem Cell Function and Aging
Park, Y., & Gerson, S. L. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104546 · Cited by 167
The genetics of dyskeratosis congenita
Mason, P. J., & Bessler, M. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.11.002 · Cited by 161
“Several studies showed that in these families (and families with TERT mutations) age specific telomere lengths are shorter in later generations(49, 54, 55).”
BackgroundSelf-citationDu, H.-Y., Pumbo, E., Ivanovich, J., An, P., Maziarz, R. T., Reiss, U. M., Chirnomas, D., Shimamura, A., Vlachos, A., Lipton, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-07-166421 · Cited by 158
“This group included two unrelated patients in whom we previously identified large TERC gene deletions.(5,36) We have previously identified the G58A and G228A transitions within the TERC gene as rare polymorphisms in the normal African American population.”
BackgroundSelf-citationArchitecture of human telomerase RNA
Zhang, Q., Kim, N.-K., & Feigon, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100279108 · Cited by 154
Hartmann, N., Boehner, M., Groenen, F., & Kalb, R. (2010) · Depression and Anxiety · doi:10.1002/da.20749 · Cited by 156
Human diseases of telomerase dysfunction: insights into tissue aging
Garcia, C. K., Wright, W. E., & Shay, J. W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm644 · Cited by 157
“Regardless of the pattern of genetic inheritance, all patients with DKC have very short telomeres, implying a common pathway underlying the mechanism of this disease (33,39,41,47).”
BackgroundInfluentialTelomere instability in the male germline
Baird, D. M., Britt-Compton, B., Rowson, J., Amso, N. N., Gregory, L., & Kipling, D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi424 · Cited by 154
“The resulting haploinsufficiency for telomerase causes a progressive shortening of telomeres between generations and disease anticipation, whereby the severity of the condition increases and the age of onset decreases (32).”
BackgroundTelomeres and Mitochondria in the Aging Heart
Moslehi, J., DePinho, R. A., & Sahin, E. (2012) · Circulation Research · doi:10.1161/circresaha.111.246868 · Cited by 148
Younger Age of Cancer Initiation Is Associated with Shorter Telomere Length in Li-Fraumeni Syndrome
Tabori, U., Nanda, S., Druker, H., Lees, J., & Malkin, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3682 · Cited by 151
Familial myelodysplastic syndromes: a review of the literature
Liew, E., & Owen, C. (2011) · Haematologica · doi:10.3324/haematol.2011.043422 · Cited by 158
“(16-100) low-set ears, micrognathia, ASD, movement”
InfluentialCapezzone, M., Marchisotta, S., Cantara, S., Busonero, G., Brilli, L., Pazaitou‐Panayiotou, K., Carli, A. F., Caruso, G., Toti, P., Capitani, S., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0080 · Cited by 152
“1995) or dyskeratosis congenita (Vulliamy et al. 2004), amolecularmechanism possibly underlying ‘anticipation’ has been recognized (unstable trinucleotide repeat expansion in Huntington’s disease and TERC (telomerase RNA component) mutation in congenital dyscheratosis).”
BackgroundProgerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria
Chojnowski, A., Ong, P. F., Wong, E. S., Lim, J. S., Mutalif, R. A., Navasankari, R., Dutta, B., Yang, H., Liow, Y. Y., Sze, S. K., et al. (2015) · eLife · doi:10.7554/elife.07759 · Cited by 147
“In this respect, HGPS may be quite different from dyskeratosis congenita (DC), a premature ageing disorder that is caused by defects in telomerase that particularly affects stem cell maintenance (Vulliamy et al., 2004).”
BackgroundHartmann, N., Reichwald, K., Lechel, A., Graf, M., Kirschner, J., Dorn, A., Tozzini, E. T., Wellner, J., Platzer, M., Rudolph, K. L., et al. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.01.003 · Cited by 173
“…several human syndromes such as dyskeratosis congenita, aplastic anemia and idiopathic pulmonary fibrosis that are caused by mutations in the telomerase genes and are characterised by increased shortening of telomeres with age (Vulliamy et al., 2004; Yamaguchi et al., 2005; Tsakiri et al., 2007).”
BackgroundIt all comes together at the ends: Telomerase structure, function, and biogenesis
Podlevsky, J. D., & Chen, J. J.-L. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.11.002 · Cited by 144
Schaetzlein, S., Nalapareddy, K., Ju, Z., Lechel, A., Stępczyńska, A., Lilli, D. R., Clark, A. B., Rudolph, C., Kühnel, F., Wei, K., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.029 · Cited by 167
Unraveling the pathogenesis of Hoyeraal–Hreidarsson syndrome, a complex telomere biology disorder
Glousker, G., Touzot, F., Revy, P., Tzfati, Y., & Savage, S. A. (2015) · British Journal of Haematology · doi:10.1111/bjh.13442 · Cited by 141
“Genetic anticipation, the worsening of a disease phenotype in successive generations, has been reported in DC and could conceivably also result in a child with HH (Vulliamy et al, 2004; Savage & Bertuch, 2010).”
BackgroundTelomere Length as Cardiovascular Aging Biomarker
De Meyer, T., Nawrot, T., Bekaert, S., De Buyzere, M. L., Rietzschel, E. R., & Andrés, V. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.014 · Cited by 139
Dyskeratosis congenita as a disorder of telomere maintenance
Nelson, N. D., & Bertuch, A. A. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.06.008 · Cited by 140
“This relationship is further exemplified in autosomal dominant DC in which there is a progressive decrease in the average telomere length and an accumulation of the shortest telomeres in mutation carriers across generations [23, 34].”
BackgroundStrong, M. A., Vidal-Cardenas, S. L., Karim, B., Yu, H., Guo, N., & Greider, C. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05312-11 · Cited by 139
“In these autosomal dominant families, the genetic anticipation describes a worsening of the phenotype and an earlier onset of disease in the later generations (4, 73).”
BackgroundGoldin, L. R., Björkholm, M., Kristinsson, S. Y., Turesson, I., & Landgren, O. (2009) · Haematologica · doi:10.3324/haematol.2008.003632 · Cited by 130
Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
“Furthermore, senescent cells are resistant to apoptosis (Wang, 1995; Hampel et al., 2005), suggesting that senescent cells may accumulate over the lifespan of an organism.”
BackgroundDyskeratosis congenita: The diverse clinical presentation of mutations in the telomerase complex
Vulliamy, T., & Dokal, I. S. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.017 · Cited by 133
Self-citationCairney, C. J., & Keith, W. N. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.025 · Cited by 140
The Role of Telomeres in Human Disease
Armanios, M. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-010422-091101 · Cited by 126
“The genetic anticipation is mediated by the short TL, which is inherited along with the deleterious mutation (20, 46, 99).”
BackgroundMarrone, A., Stevens, D., Vulliamy, T., Dokal, I., & Mason, P. J. (2004) · Blood · doi:10.1182/blood-2004-05-1829 · Cited by 126
Self-citationTER1, the RNA subunit of fission yeast telomerase
Leonardi, J., Box, J. A., Bunch, J. T., & Baumann, P. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1343 · Cited by 141
“Mutations in the RNA subunit of human telomerase cause the autosomal dominant form of dyskeratosis congenita, an inherited disorder characterized by insufficient renewal capacity of cells in skin and bloo”
BackgroundThe short and long telomere syndromes: paired paradigms for molecular medicine
Stanley, S. E., & Armanios, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.004 · Cited by 124
Low abundance of telomerase in yeast: Implications for telomerase haploinsufficiency
Mozdy, A. D., & Cech, T. R. (2006) · RNA · doi:10.1261/rna.134706 · Cited by 126
“Telomeres become shorter with successive generations in DC families, concomitant with earlier and more severe disease onset (Vulliamy et al. 2004; Goldman et al. 2005).”
BackgroundVulliamy, T., & Dokal, I. S. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.04.001 · Cited by 130
Self-citationDyskeratosis congenita: telomerase, telomeres and anticipation
Marrone, A., Walne, A. J., & Dokal, I. S. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.04.004 · Cited by 134
Self-citationRevertant Somatic Mosaicism by Mitotic Recombination in Dyskeratosis Congenita
Jongmans, M. C. J., Verwiel, E. T. P., Heijdra, Y., Vulliamy, T., Kamping, E. J., Hehir-Kwa, J. Y., Bongers, E. M. H. F., Pfundt, R., van Emst, L., van Leeuwen, F. N., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.01.004 · Cited by 124
Self-citationTelomere Shortening and Alzheimer’s Disease
Cai, Z., Yan, L., & Ratka, A. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8207-9 · Cited by 128
Diagnosis of Fanconi Anemia by Diepoxybutane Analysis
Auerbach, A. D. (2003) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0807s37 · Cited by 130
De La Fuente, J., & Dokal, I. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00721.x · Cited by 119
“This increase in severity of the disease (anticipation) in successive generations has been associated with progressive telomere shortening (17) as is the case in the Terc)/) mice.”
BackgroundSelf-citationWu, Z., Qu, J., & Liu, G.-H. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00775-3 · Cited by 118
“In addition to causing diverse telomere biology disorders such as dyskeratosis congenita 188 , telomere dysregulation is also a common feature in various age-related diseases such as Alzheimer disease 189 , pulmonary fibrosis 190 , Duchenne muscular dystrophy 97 , metabolic diseases 191 ,…”
Variation at theTERTlocus and predisposition for cancer
Baird, D. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239941000147x · Cited by 129
“Sciences of the United States of America 102, 17119-17124 117 Vulliamy, T. et al. (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nature Genetics 36, 447-449 118 Kirwan, M. et al. (2008) Circulating haematopoietic progenit…”
BackgroundInfluentialPhysiological assembly and activity of human telomerase complexes
Collins, K. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.008 · Cited by 133
“Finally, disease onset can be accelerated by inheritance of shorter-than-normal telomeres along with the gene mutation (Vulliamy et al., 2004).”
BackgroundPremature aging in telomerase-deficient zebrafish
Anchelin, M., Alcaraz-Pérez, F., Martínez, C. M., Bernabé-García, M., Mulero, V., & Cayuela, M. L. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011635 · Cited by 114
“Moreover, this correlated with the better survival of the offspring from younger mutant males and, therefore, is indicative of an anticipation phenomenon related with telomere length, which has been described in individuals with DC (Armanios et al., 2005; Vulliamy et al., 2004).”
Arnoult, N., Schluth-Bolard, C., Letessier, A., Drascovic, I., Bouarich-Bourimi, R., Campisi, J., Kim, S.-H., Boussouar, A., Ottaviani, A., Magdinier, F., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000920 · Cited by 118
“In vivo, telomere shortening in haematopoietic tissues has been estimated about 25–35 bp/year, although this pace is accelerated during the first years of life and also under stress or pathological conditions [10–16].”
Background
Metadata
- Authors
- Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I.
- Affiliations
- Hammersmith Hospital (GB)
- Washington University in St. Louis (US)
- Corresponding author
- Mason, Philip J
- Venue
- Nature Genetics
- Published
- 2004-04-18
- Volume
- 36
- Issue
- 5
- Pages
- 447-449
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2025843494
- Cited by
- 461
- References
- 15
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 11 · 2022: 17 · 2021: 16 · 2020: 19 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 18 · 2015: 15 · 2014: 28 · 2013: 26 · 2012: 15
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- dyskeratosis congenita, telomere shortening, TERC mutations, telomerase RNA, telomerase, bone marrow failure, autosomal dominant inheritance
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Family, Female, Genes, Dominant, Humans, Male, Middle Aged, Mutation, Pedigree, RNA, Telomere, Sequence Deletion, Telomerase, Dyskeratosis Congenita
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.